• Search results for Sputnik V
Image Title
spu1200

Serum Institute to start manufacturing Sputnik vaccine in September 

Serum Institute of India (SII) will start production of Sputnik vaccine at the company's facilities in September, Russian Direct Investment Fund (RDIF) said on Tuesday

Published on 13th July 2021
COVID-19-Vaccine-6-3

Students travelling to study abroad worried about visa cancellation over COVID vaccine shortage

Indian students who have received Covaxin or Russia's Sputnik V vaccine are being asked to inoculate again across several international institutes as these vaccines are yet to be approved by WHO

Published on 9th June 2021
spu1200

Apollo, Dr Reddy's to begin vaccination with Sputnik V, first phase to kick off in Hyderabad

The first phase of the programme will kick off with vaccinations in Hyderabad on Monday and in Visakhapatnam on Tuesday (May 18) at Apollo facilities

Published on 17th May 2021
sputnikV-reuters-new

COVID-19: Russian vaccine Sputnik V to be priced at Rs 995 per dose, first dose administered in Hyderabad 

Sputnik V uses two different vectors for the two shots in a course of vaccination. Its efficacy was determined to be 91.6 per cent as per a published article in the medical journal Lancet

Published on 14th May 2021
download

India to get first doses of Sputnik V vaccine by May 1, says Russian Direct Investment Fund

Meanwhile, Indian doctors are looking forward to getting access to Russia's Sputnik V vaccine soon

Published on 27th April 2021
sputnikV-reuters-new

India to produce 850 million units of Russian vaccine Sputnik V annually, says RDIF

Sputnik V will be the third vaccine to be used in India against coronavirus. In January, DCGI had given the emergency use authorisation for two COVID-19 vaccines

Published on 13th April 2021
covid_vaccine

Expert panel recommends granting approval to COVID vaccine Sputnik V for emergency use in India

Sputnik V has demonstrated an efficacy rate of 91.6 per cent in the interim analysis of phase 3 clinical trial, which included data on 19,866 volunteers in Russia

Published on 12th April 2021
Proper-storage-temperature-is-crucial-to-vaccine-potency

COVID-19 vaccine Sputnik V gets nod for clinical trials in India

Sputnik V, an adenovirus vector-based vaccine, was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, along with the Russian Direct Investment Fund

Published on 17th October 2020
vaccine

The first batch of Russian vaccine produced for civilian circulation

Russia last month registered the "Sputnik V", becoming the first country to approve a Covid-19 vaccine. On August 15, the Russian Health Ministry announced the launch of the vaccine production

Published on 8th September 2020

Search results 1 - 9 of 26